Yuxia Liu
PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Discovery of the first-in-class highly potent FXR/HSD17B13 dual modulator for the treatment of metabolic dysfunction-associated steatohepatitis.
Journal: Bioorganic chemistry
Published: January 24, 2026
Discovery of Highly Potent and Orally Available CCNK Molecular Glue Degraders as Broad-Spectrum Antitumor Agents.
Journal: Journal of medicinal chemistry
Published: October 30, 2025
Discovery of the First-In-Class HSD17B13/PPAR Multitarget Modulators for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.
Journal: Journal of medicinal chemistry
Published: October 15, 2025
Discovery of Highly Potent, Selective, and Liver-Targeting HSD17B13 Inhibitor with Robust In Vivo Anti-MASH Activity.
Journal: Journal of medicinal chemistry
Published: May 19, 2025
Discovery of the first-in-class FABP/PPAR multiple modulator for the treatment of metabolic dysfunction-associated steatohepatitis.
Journal: European journal of medicinal chemistry
Published: February 11, 2025
A H2O2 responsive self-activatable fluorescent probe and pro-photosensitizer based on a pyridine-chalcone skeleton.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: January 27, 2025
Isolation, structural characterization of natural chondroitin sulfate oligosaccharides and their binding study with anti-angiogenic factors.
Journal: Carbohydrate polymers
Published: September 26, 2024
Design, synthesis, and biological evaluation of novel highly potent FXR agonists bearing piperidine scaffold.
Journal: European journal of medicinal chemistry
Published: September 05, 2024
Discovery of the FXR/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea.
Journal: Bioorganic chemistry
Published: August 12, 2024
Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors.
Journal: European journal of medicinal chemistry
Published: May 01, 2024
Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH.
Journal: European journal of medicinal chemistry
Published: November 06, 2023
Rapid quantification of grapeseed oil multiple adulterations using near-infrared spectroscopy coupled with a novel double ensemble modeling method.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: September 21, 2023
Last Updated: 09/26/2026